* Minerva Neurosciences Inc NERV.OQ NERV.O is expected
to show
no change in quarterly revenue when it reports results on
August 2 (estimated) for the period ending June 30 2024
*
* LSEG's mean analyst estimate for Minerva Neurosciences
Inc is
for a loss of 97 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $7.00, above its last closing price
of $3.03.
This summary was machine generated July 31 at 13:58 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)